Search Within

Ingo K Mellinghoff

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (137)
  2. Journal Article (106)
  3. Review (11)
  4. Correspondence (4)
  5. Research Letter (4)
  6. Conference Paper (2)
  7. Editorial (2)
  8. Guidelines (2)
  9. Book Section (1)
Groups
  1. GSK Faculty (269)
  2. Human Oncology and Pathogenesis Program (269)
  3. Tow Center for Developmental Oncology (TCDO) (269)
  4. Radiology, Department of (75)
  5. Department of Pathology and Laboratory Medicine (69)
  6. Sloan Kettering Institute Postdocs (62)

More Groups

People
  1. Lisa De Angelis (56)
  2. Thomas Kaley (45)
  3. Robert Young (43)
  4. Christian Grommes (39)
  5. Elena Pentsova (39)
  6. Alexandra Miller (37)

More People

Years
  1. 2025 (1)
  2. 2024 (28)
  3. 2023 (33)
  4. 2022 (24)
  5. 2021 (15)
  6. 2020 (23)

More Years

Publications
  1. Neuro-Oncology (84)
  2. Journal of Clinical Oncology (40)
  3. Clinical Cancer Research (13)
  4. Cancer Research (9)
  5. Blood (7)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. Oxford University Press (93)
  2. American Society of Clinical Oncology (44)
  3. American Association for Cancer Research (30)
  4. Nature Publishing Group (20)
  5. American Society of Hematology (7)
  6. Springer (7)

More Publishers

Results (269)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • INDIGO: A randomized, double-blinded, phase III study of vorasidenib versus placebo in IDH1 or IDH2 low-grade glioma
    Meeting Abstract

    Blumenthal, D.; Mellinghoff, I. K.; van den Bent, M. J.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Welsh, L.; Mason, W.; Hottinger, A. F.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Integration of neuroimaging, patient-reported outcomes, and genetics in IDH-mutant gliomas
    Meeting Abstract

    Bhatia, A.; Adams, W.; Dono, A.; Esquenazi, Y.; Clemons, K.; Dey, M.; Young, R.; Mellinghoff, I.; Sands, S.; Paulsen, J. S.
    Annals of Neurology (2023)

    Fulltext@MSK | Save
  • CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
    Research Letter

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Reiner, A. S.; Cimera, R.; Nandakumar, S.; Price, A.; Vanderbilt, C.; Fahy, T.; Young, R. J.; more...
    Acta Neuropathologica (2023)

    Fulltext@MSK | Save
  • Flashback foreword: Bevacizumab and irinotecan in recurrent glioblastoma
    Editorial

    Mellinghoff, I. K.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies
    Meeting Abstract

    Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • IDH-mutant astrocytomas with primitive neuronal component are aggressive tumors characterized by alterations in RB1 and TP53
    Meeting Abstract

    Slocum, C.; Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Brannon, R.; Ladanyi, M.; Miller, A.; Pentsova, E.; Tabar, V.; Young, R.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Vorasidenib in IDH1- or IDH2-mutant low-grade glioma
    Journal Article

    Mellinghoff, I. K.; van den Bent, M. J.; Blumenthal, D. T.; Touat, M.; Peters, K. B.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Welsh, L.; Mason, W. P.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma
    Journal Article

    Grommes, C.; Pentsova, E.; Schaff, L. R.; Nolan, C. P.; Kaley, T.; Reiner, A. S.; Panageas, K. S.; Mellinghoff, I. K.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save